학술논문
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
Document Type
Article
Author
von Groote-Bidlingmaier, Florian; Patientia, Ramonde; Sanchez, Epifanio; Balanag, Vincent, Jr; Ticona, Eduardo; Segura, Patricia; Cadena, Elizabeth; Yu, Charles; Cirule, Andra; Lizarbe, Victor; Davidaviciene, Edita; Domente, Liliana; Variava, Ebrahim; Caoili, Janice; Danilovits, Manfrid; Bielskiene, Virgaine; Staples, Suzanne; Hittel, Norbert; Petersen, Carolyn; Wells, Charles; Hafkin, Jeffrey; Geiter, Lawrence J; Gupta, Rajesh
Source
In The Lancet Respiratory Medicine March 2019 7(3):249-259
Subject
Language
ISSN
2213-2600